Cancer Monoclonal Antibodies Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

Jun 2022| TBR1163D| TBRC (Publisher)

Report Highlights

Including: 1) By Monoclonal Antibody Therapies: Avastin; Herceptin; Keytruda; Opdivo; Darzalex; Perjeta; Others
2) By Application: Breast Cancer; Blood Cancer; Lung Cancer; Brain Tumor; Colorectal Cancer; Cervical Cancer; Gastric Cancer; Others
3) By End-User : Hospitals; Research Laboratories; Others
Covering: F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Bristol Myers Squibb Company; Johnson & Johnson; Amgen Inc.

Cancer Monoclonal Antibodies Global Market Opportunities And Strategies To 2030: COVID 19 Growth And Change from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cancer monoclonal antibodies market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for cancer monoclonal antibodies? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cancer monoclonal antibodies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider cancer monoclonal antibodies market; and compares it with other markets.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by monoclonal antibody therapies, segmentation by application, and segmentation by end user.
  • Market Characteristics – The market characteristics section of the report defines and explains the cancer monoclonal antibodies market. This chapter also defines and describes goods and related services covered in the report.
  • Trends And Strategies – This chapter describes the major trends shaping the global cancer monoclonal antibodies market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact Of COVID-19 – This chapter discusses the impact of COVID-19 on the cancer monoclonal antibodies market.
  • Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global cancer monoclonal antibodies market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for cancer monoclonal antibodies companies in terms of product/service offerings, geographic expansion, price offerings, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

 

 

Scope

Markets Covered:

  • By Monoclonal Antibody Therapies: Avastin; Herceptin; Keytruda; Opdivo; Darzalex; Perjeta; Others
  • By Application: Breast Cancer; Blood Cancer; Lung Cancer; Brain Tumor; Colorectal Cancer; Cervical Cancer; Gastric Cancer; Others
  • By End-Use : Hospitals; Research Laboratories; Others

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co., Inc.; Bristol Myers Squibb Company; Johnson & Johnson; Amgen Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cancer monoclonal antibodies indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 2 : Global Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 3 : Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 4 : Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 5 : Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 6 : Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 7 : Global Cancer Monoclonal Antibodies Market, Segmentation By End User, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 8 : Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 9 : Global Cancer Monoclonal Antibodies Market, By Region, Historic and Forecast, 2015-2020, 2025F, 2030F, %
  • Table 10 : Global Cancer Monoclonal Antibodies Market, By Region, Historic and Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 11 : Global Cancer Monoclonal Antibodies Market, By Country, Historic and Forecast, 2015-2020, 2025F, 2030F, %
  • Table 12 : Global Cancer Monoclonal Antibodies Market, By Country, Historic and Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 13 : Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 14 : Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 15 : Asia Pacific Cancer Prevalence, Estimated Average Expenditure, 2019, $
  • Table 16 : Asia-Pacific Oncology Drugs Market, 2015-2025, $Billion
  • Table 17 : Asia-Pacific Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 18 : Asia-Pacific Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 19 : Asia-Pacific Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 20 : Asia-Pacific Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 21 : China GDP Per Capita, 2015-2020, $
  • Table 22 : China, Population By Age Group, 2015-2023, Thousands
  • Table 23 : China Cancer Prevalence, Estimated Average Expenditure, 2019, $
  • Table 24 : China Oncology Drugs Market, 2015-2025, $Billion
  • Table 25 : China Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 26 : China Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 27 : China Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 28 : China Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 29 : India Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 30 : India Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 31 : India Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 32 : India Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 33 : Japan Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 34 : Japan Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 35 : Japan Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 36 : Japan Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 37 : Australia Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 38 : Australia Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 39 : Australia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 40 : Australia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 41 : Indonesia Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 42 : Indonesia Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 43 : Indonesia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 44 : Indonesia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 45 : South Korea Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 46 : South Korea Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 47 : South Korea Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 48 : South Korea Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 49 : Western Europe GDP Per Capita, 2015-2020, $
  • Table 50 : Western Europe Population By Age Group, By Country, 2015-2023, Thousands
  • Table 51 : Western Europe Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 52 : Western Europe Oncology Drugs Market, 2015-2025, $Billion
  • Table 53 : Western Europe Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 54 : Western Europe Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 55 : Western Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 56 : Western Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 57 : UK Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 58 : UK Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 59 : UK Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 60 : UK Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 61 : Germany Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 62 : Germany Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 63 : Germany Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 64 : Germany Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 65 : France Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 66 : France Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 67 : France Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 68 : France Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 69 : Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 70 : Eastern Europe Population By Age Group, By Country, 2015-2023, Thousands
  • Table 71 : Eastern Europe Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 72 : Eastern Europe Oncology Drugs Market, 2015-2025, $Billion
  • Table 73 : Eastern Europe Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 74 : Eastern Europe Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 75 : Eastern Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 76 : Eastern Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 77 : Russia Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 78 : Russia Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 79 : Russia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 80 : Russia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 81 : North America GDP Per Capita, 2015-2020, $
  • Table 82 : North America Population By Age Group, By Country, 2015-2023, Thousands
  • Table 83 : North America Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 84 : North America Oncology Drugs Market, 2015-2025, $Billion
  • Table 85 : North America Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 86 : North America Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 87 : North America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 88 : North America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 89 : USA GDP Per Capita, 2015-2020, $
  • Table 90 : USA Population By Age Group, 2015-2023, Thousands
  • Table 91 : USA Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 92 : North America Oncology Drugs Market, 2015-2025, $Billion
  • Table 93 : USA Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 94 : USA Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 95 : USA Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 96 : USA Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 97 : South America GDP Per Capita, 2015-2020, $
  • Table 98 : South America Population By Age Group, By Country, 2015-2023, Thousands
  • Table 99 : South America Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 100 : South America Oncology Drugs Market, 2015-2025, $Billion
  • Table 101 : South America Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 102 : South America Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 103 : South America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 104 : South America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 105 : Brazil Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 106 : Brazil Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 107 : Brazil Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 108 : Brazil Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 109 : Middle East GDP Per Capita, 2015-2020, $
  • Table 110 : Middle East Population By Age Group, By Country, 2015-2023, Thousands
  • Table 111 : Middle East Oncology Drugs Market, 2015-2025, $Billion
  • Table 112 : Middle East Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 113 : Middle East Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 114 : Middle East Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 115 : Middle East Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 116 : Africa GDP Per Capita, 2015-2020, $
  • Table 117 : Africa Population By Age Group, By Country, 2015-2023, Thousands
  • Table 118 : Africa Oncology Drugs Market, 2015-2025, $Billion
  • Table 119 : Africa Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Table 120 : Africa Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Table 121 : Africa Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Table 122 : Africa Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, $ Million
  • Table 123 : Global Cancer Monoclonal Antibodies Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 124 : F. Hoffmann-La Roche Ltd-Financial Performance, 2016-2020, $ Billion
  • Table 125 : Merck & Co., Inc.-Financial Performance, 2016-2020, $ Billion
  • Table 126 : Bristol Myers Squibb Company-Financial Performance, 2016-2020, $ Billion
  • Table 127 : Johnson & Johnson-Financial Performance, 2016-2020, $ Billion
  • Table 128 : Amgen Inc.-Financial Overview, 2016 - 2020, $ Billion
  • Table 129 : Global Cancer Monoclonal Antibodies Market Size Gain ($ Million), 2020-2025, By Country
  • Table 130 : Global Cancer Monoclonal Antibodies Market Size Gain ($ Million), Segmentation By Monoclonal Antibody Therapies, 2020-2025
  • Table 131 : Global Cancer Monoclonal Antibodies Market Size Gain ($ Million), Segmentation By Application, 2020-2025
  • Table 132 : Global Cancer Monoclonal Antibodies Market Size Gain ($ Million), Segmentation By End User, 2020-2025
  • Table 133 : Cancer Monoclonal Antibodies - Market Data Sources
  • Figure 1 : Global Cancer Monoclonal Antibodies Market Segmentation By Monoclonal Antibody Therapies
  • Figure 2 : Global Cancer Monoclonal Antibodies Market Segmentation By Application
  • Figure 3 : Global Cancer Monoclonal Antibodies Market Segmentation By End User
  • Figure 4 : Global Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 5 : Global Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 6 : Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 7 : Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 8 : Global Cancer Monoclonal Antibodies Market, Segmentation By End User, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 9 : Global Cancer Monoclonal Antibodies Market, By Region, Historic and Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 10 : Global Cancer Monoclonal Antibodies Market, By Country, Historic and Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 11 : Asia-Pacific Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 12 : Asia-Pacific Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 13 : Asia-Pacific Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 14 : China Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 15 : China Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 16 : China Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 17 : India Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 18 : India Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 19 : India Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 20 : Japan Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 21 : Japan Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 22 : Japan Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 23 : Australia Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 24 : Australia Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 25 : Australia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 26 : Indonesia Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 27 : Indonesia Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 28 : Indonesia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 29 : South Korea Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 30 : South Korea Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 31 : South Korea Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 32 : Western Europe Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 33 : Western Europe Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 34 : Western Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 35 : UK Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 36 : UK Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 37 : UK Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 38 : Germany Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 39 : Germany Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 40 : Germany Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 41 : France Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 42 : France Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 43 : France Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 44 : Eastern Europe Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 45 : Eastern Europe Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 46 : Eastern Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 47 : Russia Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 48 : Russia Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 49 : Russia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 50 : North America Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 51 : North America Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 52 : North America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 53 : USA Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 54 : USA Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 55 : USA Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 56 : South America Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 57 : South America Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 58 : South America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 59 : Brazil Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 60 : Brazil Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 61 : Brazil Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 62 : Middle East Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 63 : Middle East Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 64 : Middle East Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 65 : Africa Cancer Monoclonal Antibodies Market, Historic, 2015-2020, $ Million
  • Figure 66 : Africa Cancer Monoclonal Antibodies Market, Forecast, 2020-2025, 2030F, $ Million
  • Figure 67 : Africa Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic And Forecast, 2015-2020, 2025F, 2030F, %
  • Figure 68 : Global Cancer Monoclonal Antibodies Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 69 : F. Hoffmann-La Roche Ltd-Financial Performance, 2016-2020, $ Billion
  • Figure 70 : Merck & Co., Inc.-Financial Performance, 2016-2020, $ Billion
  • Figure 71 : Bristol Myers Squibb Company-Financial Performance, 2016-2020, $ Billion
  • Figure 72 : Johnson & Johnson-Financial Performance, 2016-2020, $ Billion
  • Figure 73 : Amgen Inc.-Financial Overview, 2016-2020, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Cancer Monoclonal Antibodies Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR1163C

Including: 1) By Monoclonal Antibody Therapies: Bevacizumab (Avastin); Rituximab (Rituxan); Trastuzumab (Herceptin); Cetuximab (Erbitux); Panitumumab (Vectibix); Others
2) By Application: Breast Cancer; Blood Cancer; Liver Cancer; Brain Cancer; Colorectal Cancer; Others
3) By End User: Hospitals And Clinics; Research Laboratories; Pharmacies; Others
Covering: Amgen; Bristol Myers Squibb Company; Eli Lilly and Company; F.Hoffmann-La Roche Ltd.; Genmab AS; GlaxoSmithKline

...

Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030

  • Date - Sep 2021
  • Code - TBR1163B

Including: 1) By Monoclonal Antibody Therapies: Bevacizumab (Avastin); Rituximab (Rituxan); Trastuzumab (Herceptin); Cetuximab (Erbitux); Panitumumab (Vectibix); Others
2) By Application: Breast Cancer; Blood Cancer; Liver Cancer; Brain Cancer; Colorectal Cancer; Others
3) By End User: Hospitals And Clinics; Research Laboratories; Pharmacies; Others
Covering: Amgen; Bristol Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genmab AS

...

Cancer Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change

  • Date - Dec 2020
  • Code - TBR1163A

Cancer Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change

Including: 1) By Monoclonal Antibody Therapies: Bevacizumab (Avastin); Rituximab (Rituxan); Trastuzumab (Herceptin); Cetuximab (Erbitux); Panitumumab (Vectibix); Others
2) By Application: Breast Cancer; Blood Cancer; Liver Cancer; Brain Cancer; Colorectal Cancer; Others

Covering: Amgen; Bristol Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genmab AS

Cancer Monoclonal ...

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS
Share This Report